• Consensus Rating: Moderate Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$105.11
▼ -0.68 (-0.64%)

This chart shows the closing price for ARKAY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Arkema Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARKAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARKAY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Arkema in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $105.11.

This chart shows the closing price for ARKAY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in Arkema. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/30/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/28/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/26/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/22/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/10/2023Stifel NicolausUpgradeHold ➝ Buy
3/6/2023UBS GroupUpgradeSell ➝ Neutral
3/2/2023The Goldman Sachs GroupUpgradeNeutral ➝ Buy
1/13/2023Stifel NicolausDowngradeBuy ➝ Hold
11/22/2022Berenberg BankLower TargetBuy ➝ Buy€100.00 ➝ €98.00
11/16/2022Credit Suisse GroupLower Target€80.00 ➝ €79.00
11/14/2022BarclaysLower Target€131.00 ➝ €126.00
10/10/2022Berenberg BankLower Target€131.00 ➝ €100.00
10/5/2022Morgan StanleyLower TargetUnderweight ➝ Underweight€91.00 ➝ €88.00
10/4/2022Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy€120.00 ➝ €110.00
9/9/2022Deutsche Bank AktiengesellschaftLower Target€135.00 ➝ €120.00
9/1/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral
8/24/2022Credit Suisse GroupReiterated RatingOutperform
7/20/2022Credit Suisse GroupLower TargetUnderperform ➝ Underperform€103.00 ➝ €87.00
7/18/2022Morgan StanleyLower TargetUnderweight ➝ Underweight€105.00 ➝ €91.00
7/14/2022BarclaysBoost Target€129.00 ➝ €131.00
7/14/2022UBS GroupDowngradeNeutral ➝ Sell
7/12/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
7/6/2022Stifel NicolausLower TargetBuy ➝ Buy€139.00 ➝ €123.00
7/5/2022Deutsche Bank AktiengesellschaftLower Target€145.00 ➝ €135.00
4/8/2022Credit Suisse GroupBoost Target€101.00 ➝ €103.00
3/30/2022Kepler Capital MarketsDowngradeBuy ➝ Hold
2/25/2022The Goldman Sachs GroupBoost Target€145.00 ➝ €146.00
2/25/2022JPMorgan Chase & Co.Boost Target€136.00 ➝ €142.00
2/4/2022BarclaysBoost Target€124.00 ➝ €129.00
1/21/2022JPMorgan Chase & Co.Boost Target€134.00 ➝ €136.00
12/13/2021Morgan StanleyDowngradeEqual Weight ➝ Underweight
12/8/2021UBS GroupLower TargetNeutral ➝ Neutral€123.00 ➝ €120.00
12/7/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
11/11/2021JPMorgan Chase & Co.Reiterated RatingOverweight
11/11/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/14/2021Morgan StanleyReiterated RatingEqual Weight
10/14/2021Jefferies Financial GroupInitiated CoverageBuy
10/13/2021UBS GroupReiterated RatingNeutral
9/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/3/2021CitigroupInitiated CoverageBuy
9/3/2021HSBCUpgradeHold ➝ Buy
8/19/2021Morgan StanleyReiterated RatingEqual Weight
8/13/2021JPMorgan Chase & Co.Reiterated RatingOverweight
7/30/2021Credit Suisse GroupReiterated RatingUnderperform
7/14/2021UBS GroupReiterated RatingNeutral
7/12/2021Credit Suisse GroupSet TargetUnderperform$126.72
7/7/2021BarclaysReiterated RatingEqual Weight
7/2/2021JPMorgan Chase & Co.Reiterated RatingOverweight
6/10/2021Redburn PartnersUpgradeSell ➝ Neutral
5/18/2021BarclaysReiterated RatingEqual Weight
5/12/2021Credit Suisse GroupReiterated RatingUnderperform
5/11/2021Berenberg BankReiterated RatingHold
5/7/2021JPMorgan Chase & Co.Reiterated RatingOverweight
5/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/30/2021BarclaysReiterated RatingEqual Weight
4/14/2021UBS GroupReiterated RatingNeutral
4/12/2021JPMorgan Chase & Co.Reiterated RatingOverweight
3/9/2021Stifel NicolausUpgradeHold ➝ Buy
3/3/2021Berenberg BankReiterated RatingHold
3/1/2021Kepler Capital MarketsUpgradeHold ➝ Buy
2/2/2021Redburn PartnersDowngradeBuy ➝ Sell
1/26/2021Credit Suisse GroupDowngradeOutperform ➝ Underperform
12/18/2020Societe GeneraleReiterated RatingHold
12/8/2020UBS GroupReiterated RatingNeutral
12/7/2020BarclaysReiterated RatingEqual Weight
12/7/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight
11/6/2020Credit Suisse GroupReiterated RatingOutperform
10/6/2020Morgan StanleyReiterated RatingOverweight
10/5/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/22/2020CitigroupReiterated RatingBuy
8/14/2020HSBCDowngradeBuy ➝ Hold
8/4/2020JPMorgan Chase & Co.Reiterated RatingOverweight
8/3/2020UBS GroupReiterated RatingNeutral
7/13/2020Morgan StanleyReiterated RatingOverweight
7/8/2020UBS GroupReiterated RatingNeutral
6/19/2020Credit Suisse GroupReiterated RatingOutperform
6/1/2020UBS GroupReiterated RatingNeutral
3/30/2020Morgan StanleyReiterated RatingOverweight
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/4/2020The Goldman Sachs GroupUpgradeSell ➝ Buy
2/25/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
2/4/2020Kepler Capital MarketsUpgradeReduce ➝ Hold
1/16/2020BarclaysDowngradeOverweight ➝ Equal Weight
4/3/2019Berenberg BankInitiated CoverageHold
(Data available from 2/21/2019 forward)

News Sentiment Rating

1.06 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2023
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2023
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/21/2024

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Arkema logo
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It also provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. In addition, the company offers performance polymers, such as long chain polyamides and fluoropolymers; and performance additives comprising of thiochemicals, specialty surfactants, organic and hydrogen peroxides, and molecular sieves. Further, it provides coating solutions comprising EU/US acrylics and coating resins; sartomer photocure resins and coatex rheology additives; decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbents, water treatment and oil and gas extraction, and 3D printing and electronics industries. Additionally, the company offers fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.
Read More

Today's Range

Now: $105.11
Low: $104.18
High: $105.11

50 Day Range

MA: $108.33
Low: $98.48
High: $114.15

52 Week Range

Now: $105.11
Low: $85.58
High: $114.15

Volume

1,127 shs

Average Volume

1,075 shs

Market Capitalization

$7.89 billion

P/E Ratio

18.64

Dividend Yield

2.93%

Beta

1.4

Frequently Asked Questions

What sell-side analysts currently cover shares of Arkema?

The following Wall Street sell-side analysts have issued reports on Arkema in the last twelve months: Stifel Nicolaus, The Goldman Sachs Group, Inc., and UBS Group AG.
View the latest analyst ratings for ARKAY.

What is the current price target for Arkema?

0 Wall Street analysts have set twelve-month price targets for Arkema in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Arkema in the next year.
View the latest price targets for ARKAY.

What is the current consensus analyst rating for Arkema?

Arkema currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ARKAY.

What other companies compete with Arkema?

How do I contact Arkema's investor relations team?

Arkema's physical mailing address is 420 rue d`Estienne d Orves, Colombes Cedex I0, 92700. The basic materials company's listed phone number is (314) 900-8080 and its investor relations email address is [email protected]. The official website for Arkema is www.arkema.com. Learn More about contacing Arkema investor relations.